Skip to main content

Teva is said to face U.S. charge in price-fixing inquiry

By TheStreet  
   August 25, 2020

Teva Pharmaceutical shares were lower after a report said U.S. prosecutors are preparing to charge the drugmaker with conspiring with competitors to raise prices for generic drugs. 

Full story


Get the latest on healthcare leadership in your inbox.